Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuti

Showing results (221-230 of 596) with videos related to

Pageof 60
Sort By:
Pharmacotherapy|July 12, 2005
Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenemJoseph L Kuti, Sheryl Horowitz, Charles H Nightingale, et al.
Annals of Tropical Paediatrics|December 1, 1987
Bacteriological quality of raw human milk: effect of storage in a refrigeratorS A Olowe, I Ahmed, S F Lawal, et al.
Journal of Clinical Pharmacology|September 22, 2006
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patientsChonghua Li, Joseph L Kuti, Charles H Nightingale, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2013
In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposureAmira A Bhalodi, Mao Hagihara, David P Nicolau, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 2, 2008
Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbiditiesL O Alekwe, O Kuti, E O Orji, et al.
Pharmacotherapy|November 26, 2008
Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infectionsSomvadee Laohavaleeson, Steven L Barriere, David P Nicolau, et al.
Lancet (London, England)|August 21, 1971
Intestinal absorption of lactose in Nigerian ethnic groupsN Kretchmer, O Ransome-Kuti, R Hurwitz, et al.
International Journal of Molecular Sciences|July 29, 2023
Recruitment of Corticotropin-Releasing Hormone (CRH) Neurons in Categorically Distinct Stress Reactions in the Mouse BrainKrisztina Horváth, Balázs Juhász, Dániel Kuti, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2023
<i>In vitro</i> activity of imipenem/relebactam against <i>Pseudomonas aeruginosa</i> isolated from patients with cystic fibrosisVictor H Ruiz, Andrew Fratoni, David P Nicolau, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 28, 2003
Economic benefit of a meropenem dosage strategy based on pharmacodynamic conceptsJoseph L Kuti, Dana Maglio, Charles H Nightingale, et al.
Pageof 60

Showing results (221-230 of 596) with videos related to

Sort By:
Pageof 60
Pharmacotherapy|July 12, 2005
Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenemJoseph L Kuti, Sheryl Horowitz, Charles H Nightingale, et al.
Annals of Tropical Paediatrics|December 1, 1987
Bacteriological quality of raw human milk: effect of storage in a refrigeratorS A Olowe, I Ahmed, S F Lawal, et al.
Journal of Clinical Pharmacology|September 22, 2006
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patientsChonghua Li, Joseph L Kuti, Charles H Nightingale, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2013
In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposureAmira A Bhalodi, Mao Hagihara, David P Nicolau, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 2, 2008
Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbiditiesL O Alekwe, O Kuti, E O Orji, et al.
Pharmacotherapy|November 26, 2008
Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infectionsSomvadee Laohavaleeson, Steven L Barriere, David P Nicolau, et al.
Lancet (London, England)|August 21, 1971
Intestinal absorption of lactose in Nigerian ethnic groupsN Kretchmer, O Ransome-Kuti, R Hurwitz, et al.
International Journal of Molecular Sciences|July 29, 2023
Recruitment of Corticotropin-Releasing Hormone (CRH) Neurons in Categorically Distinct Stress Reactions in the Mouse BrainKrisztina Horváth, Balázs Juhász, Dániel Kuti, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2023
<i>In vitro</i> activity of imipenem/relebactam against <i>Pseudomonas aeruginosa</i> isolated from patients with cystic fibrosisVictor H Ruiz, Andrew Fratoni, David P Nicolau, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 28, 2003
Economic benefit of a meropenem dosage strategy based on pharmacodynamic conceptsJoseph L Kuti, Dana Maglio, Charles H Nightingale, et al.
Pageof 60